Re-cap25 Apr 2019 13:42
Ahead of results in June just having a quick recap as I've learned to boil down Chris Gilbert's commentary over the years.
"Revenue from the sale of marble products for the six months to 30 June 2018 increased 26 % to €615k (H1 2017: €330k)."
"Loss for the six months to 30 June 2018 of €816k (six months to 30 June 2017: €1,427k)"
"Unaudited sales for the year ended 31 December 2018 of c. €1.4 million, (2017 - c. €1.2million)." +16.6%
"Block order book from existing customers for the year ended 31 December 2019 of around €3 million."
(in 2017 they forecast €4.1m and the year end result was €1.2m - the missing sales clearly didn't show up in H1 18 which came as a bit of a shock to me - so I'll believe it when I see it) "In light of this new agreement, the Company has increased its estimate of its order book in 2017 to 4.1m." RNS dated 7th February, 2017.
"We have seen encouraging signs in the development of our customer base, with a core of recurring block sale customers, with steady and regular demand for our material. We expect these customers to form the backbone of expected revenues in 2019."
Q. What about the cut & polished revenue from the machinery we invested money in?
Revenue of 1.4m euro and a market cap of £18.5m puts us on approx. 14.5 x sales with a slight adjustment for exchange rates. P/e - no earnings and no divi.
For comparison, Mermeren Kombinat AD Prilep is currently trading on 7.6 x sales, a p/e of 14.83 and pays a divi of 6.74%. https://www.bloomberg.com/quote/MERKO:GA
You can read their 2018 year end report here:
http://www.mermeren.com/investor_relations/2019/en/Annual%20Report%202018.pdf
Q. What happened to the US Sales & Distribution agreement referred to in the RNS dated 10th August, 2017?
"In consideration, and subject to achieving minimum sales volumes of US$1.5 million over the three years as determined by the Company,
a) Pristine Stone will be granted priority rights to sell Fox Marble material in the United States.
b) Pristine Stone will be granted 750,000 warrants issued in equal installments over three years at an exercise price of 2p over market price on the day of issue."